Literature DB >> 11892844

Antimicrobial peptides from the skin of the Japanese mountain brown frog, Rana ornativentris.

J B Kim1, S Iwamuro, F C Knoop, J M Conlon.   

Abstract

Six peptides with antimicrobial activity were isolated from an extract of freeze-dried skin of the Japanese mountain brown frog Rana ornativentris. Two structurally related peptides (brevinin-20a GLFNVFKGALKTAGKHVAGSLLNQLKCKVSGGC, 11 nmol/g dried tissue, and brevinin-20b GIFNVFKGALKTAGKHVAGSLLNQLKCKVSGEC, 170 nmol/g) belong to the brevinin-2 family, previously identified in Asian and European, but not North American, Ranid frogs. Four peptides (temporin-10a FLPLLASLFSRLL.NH2, 13 nmol/g; temporin-10b FLPLIGKILGTI L.NH2, 350 nmol/g; temporin-10c FLPLLASLFSRLF.NH2, 14 nmol/g; and temporin-10d FLPLLASLFSGLF.NH2, 8 nmol/g) are members of the temporin family first identified in the European common frog Rana temporaria but also found in the skins of North American Ranids. The brevinin-2 peptides showed broad-spectrum activity against the gram-positive bacterium, Staphylococcus aureus, the gram-negative bacterium, Escherichia coli and the yeast Candida albicans, whereas the temporins showed potent activity only against S. aureus. The brevinins and temporins belong to the class of cationic antimicrobial peptides that adopt an amphipathic alpha-helical conformation but it is significant that temporin-10d, which lacks a basic amino acid residue, is still active against S. aureus (minimum inhibitory concentration=13 microM compared with 2 microM for temporin-10a). This suggests that strong electrostatic interaction between the peptide and the negatively charged phospholipids of the cell membrane is not an absolute prerequisite for antimicrobial activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11892844     DOI: 10.1034/j.1399-3011.2001.00947.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  9 in total

1.  Activities of temporin family peptides against the chytrid fungus (Batrachochytrium dendrobatidis) associated with global amphibian declines.

Authors:  Louise A Rollins-Smith; Cynthia Carey; J Michael Conlon; Laura K Reinert; Jennifer K Doersam; Tomas Bergman; Jerzy Silberring; Hilkka Lankinen; David Wade
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 2.  Nonmammalian vertebrate antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 3.  Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action.

Authors:  Maria Luisa Mangoni; Yechiel Shai
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

4.  Antibacterial, antifungal, anticancer activities and structural bioinformatics analysis of six naturally occurring temporins.

Authors:  Biswajit Mishra; Xiuqing Wang; Tamara Lushnikova; Yingxia Zhang; Radha M Golla; Jayaram Lakshmaiah Narayana; Chunfeng Wang; Timothy R McGuire; Guangshun Wang
Journal:  Peptides       Date:  2018-05-26       Impact factor: 3.750

5.  Differentiation of Central Slovenian and Moscow populations of Rana temporaria frogs using peptide biomarkers of temporins family.

Authors:  T Yu Samgina; I D Vasileva; S V Kovalev; P Trebse; G Torkar; A K Surin; R A Zubarev; A T Lebedev
Journal:  Anal Bioanal Chem       Date:  2021-07-07       Impact factor: 4.142

Review 6.  Nanotechnology-Based Delivery Systems for Antimicrobial Peptides.

Authors:  Adewale Oluwaseun Fadaka; Nicole Remaliah Samantha Sibuyi; Abram Madimabe Madiehe; Mervin Meyer
Journal:  Pharmaceutics       Date:  2021-10-26       Impact factor: 6.321

Review 7.  Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides.

Authors:  Marjoriane de Amaral; Julia Ienes-Lima
Journal:  Virus Res       Date:  2022-04-14       Impact factor: 6.286

8.  In Silico Structural Evaluation of Short Cationic Antimicrobial Peptides.

Authors:  Ilaria Passarini; Sharon Rossiter; John Malkinson; Mire Zloh
Journal:  Pharmaceutics       Date:  2018-06-21       Impact factor: 6.321

Review 9.  A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides.

Authors:  Katrina Browne; Sudip Chakraborty; Renxun Chen; Mark Dp Willcox; David StClair Black; William R Walsh; Naresh Kumar
Journal:  Int J Mol Sci       Date:  2020-09-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.